Haloperidol Lactate Injection, Solution
Product Images NDC 55154-7076

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol Lactate (NDC 55154-7076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

971e7f23 E45a 420e Bc53 3ff403e0f975 00

971e7f23 E45a 420e Bc53 3ff403e0f975 00
Label for Haloperidol Injection, USP 5 mg/mL solution for intramuscular use. The label indicates single-dose vials of 1 mL each, with a package of 5 vials. It includes storage instructions, prescription-only status, and manufacturing and distribution details by Mylan Institutional LLC and Cardinal Health. The label states the active ingredient is Haloperidol (as the lactate) 5 mg per mL, and contains preservatives methylparaben and propylparaben.*
FDA Label Image

Bag Label (Image 01)

Bag Label (Image 01)
Chemical structure diagram of Haloperidol Lactate, showing its molecular configuration with fluorine and chlorine substituents on aromatic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.